EWALL-INO: Inotuzumab ozogamicin promising as first-line therapy for BCP-ALL Presented ByProf. Patrice Chevallier, Nantes University Hospital, France TrialPhase 2, EWALL-INO ConferenceASH 2021 4 February, 2022 11:57